ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Reexamine Mandates, Samuels Suggests

February 17, 1984

Urologists support Approval Of Il-2 for Kidney Cancer

February 1, 1991

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996